Immune evasion by Staphylococci

被引:865
作者
Foster, TJ [1 ]
机构
[1] Trinity Coll Dublin, Microbiol Dept, Moyne Inst Prevent Med, Dublin 2, Ireland
基金
英国惠康基金;
关键词
D O I
10.1038/nrmicro1289
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Staphylococcus aureus can cause superficial skin infections and, occasionally, deep-seated infections that entail spread through the blood stream. The organism expresses several factors that compromise the effectiveness of neutrophils and macrophages, the first line of defence against infection. S. aureus secretes proteins that inhibit complement activation and neutrophil chemotaxis or that lyse neutrophils, neutralizes antimicrobial defensin peptides, and its cell surface is modified to reduce their effectiveness. The organism can survive in phagosomes, express polysaccharides and proteins that inhibit opsonization by antibody and complement, and its cell wall is resistant to lysozyme. Furthermore, S. aureus expresses several types of superantigen that corrupt the normal humoral immune response, resulting in anergy and immunosuppression. In contrast, Staphylococcus epidermidis must rely primarily on cell-surface polymers and the ability to form a biolfilm to survive in the host.
引用
收藏
页码:948 / 958
页数:11
相关论文
共 134 条
  • [91] Bacterial fibronectin-binding proteins and endothelial cell surface fibronectin mediate adherence of Staphylococcus aureus to resting human endothelial cells
    Peacock, SJ
    Foster, TJ
    Cameron, BJ
    Berendt, AR
    [J]. MICROBIOLOGY-SGM, 1999, 145 : 3477 - 3486
  • [92] Virulent combinations of adhesin and toxin genes in natural populations of Staphylococcus aureus
    Peacock, SJ
    Moore, CE
    Justice, A
    Kantzanou, M
    Story, L
    Mackie, K
    O'Neil, G
    Day, NPJ
    [J]. INFECTION AND IMMUNITY, 2002, 70 (09) : 4987 - 4996
  • [93] How do bacteria resist human antimicrobial peptides?
    Peschel, A
    [J]. TRENDS IN MICROBIOLOGY, 2002, 10 (04) : 179 - 186
  • [94] Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides
    Peschel, A
    Otto, M
    Jack, RW
    Kalbacher, H
    Jung, G
    Götz, F
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (13) : 8405 - 8410
  • [95] Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with L-lysine
    Peschel, A
    Jack, RW
    Otto, M
    Collins, LV
    Staubitz, P
    Nicholson, G
    Kalbacher, H
    Nieuwenhuizen, WF
    Jung, G
    Tarkowski, A
    van Kessel, KPM
    van Strijp, JAG
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (09) : 1067 - 1076
  • [96] Interplay between superantigens and immunoreceptors
    Petersson, K
    Forsberg, G
    Walse, B
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2004, 59 (04) : 345 - 355
  • [97] Residues 10-18 within the C5a receptor N terminus compose a binding domain for chemotaxis inhibitory protein of Staphylococcus aureus
    Postma, B
    Kleibeuker, W
    Poppelier, MJJG
    Boonstra, M
    Van Kessel, KPM
    Van Strijp, JAG
    de Haas, CJC
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (03) : 2020 - 2027
  • [98] Chemotaxis inhibitory protein of Staphylococcus aureus binds specifically to the c5a and formylated peptide receptor
    Postma, B
    Poppelier, MJ
    van Galen, JC
    Prossnitz, ER
    van Strijp, JAG
    de Haas, CJC
    van Kessel, KPM
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 172 (11) : 6994 - 7001
  • [99] PREVOST G, 1995, INFECT IMMUN, V63, P4121
  • [100] Bacterial superantigens
    Proft, T
    Fraser, JD
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2003, 133 (03) : 299 - 306